ALLMedicine™ Urticaria Center
Research & Reviews 1,666 results
https://doi.org/10.1097/NAN.0000000000000444
Journal of Infusion Nursing : the Official Publication Of... Holmes JP, Peguero JA et. al.
Sep 24th, 2021 - Pretreatment with antihistamines for the prevention of hypersensitivity infusion reactions is recommended for certain biologics and chemotherapies. Cetirizine is the first injectable second-generation antihistamine recently approved for acute urti...
https://doi.org/10.1111/all.15090
Allergy Zuberbier T, Abdul Latiff AH et. al.
Sep 19th, 2021 - This update and revision of the international guideline for urticaria was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is a joint initia...
https://doi.org/10.1188/21.CJON.511-513
Clinical Journal of Oncology Nursing; Busack KR
Sep 18th, 2021 - Pegaspargase, a chemotherapy drug known to improve survival outcomes in acute lymphoblastic leukemia, is associated with a risk for hypersensitivity reactions. At a children's hospital in the midwestern United States, two patients developed unusua...
https://doi.org/10.1017/S1047951121003838
Cardiology in the Young; Erdogan E, Cap M et. al.
Sep 18th, 2021 - Allergic reactions related to drug use is a common entity presenting often from minor urticaria to life-threatening anaphylactoid reactions. A common but easily overlooked diagnosis, Kounis syndrome, is an established hypersensitivity coronary dis...
https://doi.org/10.1007/s12016-021-08886-x 10.1111/all.14037 10.1111/all.13397 10.1016/j.alit.2018.05.011 10.1111/bjd.19561 10.1016/j.jaad.2019.02.034 10.1111/imr.12632 10.1007/s12016-017-8628-1 10.1111/all.13949 10.1007/s12016-012-8326-y 10.1172/jci85538 10.1111/j.1365-2133.1986.tb04065.x 10.1067/mai.2001.117792 10.1371/journal.pone.0014794 10.1016/j.jaci.2017.10.035 10.1111/all.13832 10.3389/fimmu.2018.00689 10.1038/s41385-020-00336-9 10.1111/all.13567 10.1016/j.jaci.2018.05.019 10.1067/mai.2002.120954 10.1111/j.1365-2222.2005.02380.x 10.1067/mai.2001.114656 10.1111/all.14412 10.1016/j.jaci.2016.04.036 10.1016/j.autrev.2017.10.003 10.1111/j.1398-9995.2012.02879.x 10.1111/all.12786 10.1111/j.1600-065X.2008.00742.x 10.1016/j.jaci.2007.08.051 10.3389/fimmu.2019.00627 10.1016/j.jaci.2005.12.1343 10.1016/j.jaci.2006.08.043 10.1111/j.1398-9995.2009.02222.x 10.1159/000155748 10.1016/j.jaci.2020.08.018 10.1016/s0091-6749(99)70190-9 10.1007/s11739-009-0333-5 10.1016/j.jaad.2018.02.033 10.1186/s13601-018-0234-7 10.1111/all.13110 10.1097/ACI.0b013e32833c79d7 10.1007/s40257-015-0152-6 10.1111/hel.12661 10.1111/hel.12312 10.1007/s40257-020-00561-9 10.1111/all.13381 10.1111/j.1365-2133.2009.09411.x 10.1111/all.13482 10.1016/j.jaci.2016.04.051 10.1016/j.jaci.2014.05.004 10.1111/all.14015 10.2332/allergolint.13-OA-0536 10.1067/mai.2002.121309 10.1159/000339332 10.1111/bjd.13621 10.1016/j.molimm.2010.10.010 10.1159/000496162 10.1111/all.13586 10.1016/j.jaci.2014.02.036 10.1111/bjd.14768 10.1111/bjd.15104 10.1016/j.jdermsci.2019.05.008 10.2340/00015555-2941 10.1016/j.jaci.2013.04.037 10.1186/s13601-019-0275-6 10.23822/eurannaci.1764-1489.05 10.1016/j.jaci.2016.10.017 10.1111/exd.13874 10.1016/j.jaad.2020.02.041 10.1111/pai.13325 10.1038/nrd1334 10.1016/j.jaci.2015.12.1342 10.1007/s12016-020-08794-6 10.1016/j.anai.2019.11.028 10.1111/ced.13173 10.1111/all.13675 10.1016/j.jaci.2017.10.018 10.1016/j.jaip.2020.02.012 10.1016/j.jaci.2016.03.030 10.1016/j.jaci.2017.07.013 10.1016/j.jaci.2011.04.010 10.1684/ejd.2018.3454 10.1172/jci129697 10.1016/j.jaci.2017.08.007 10.2340/00015555-2654 10.1111/all.13936 10.1016/j.jaci.2016.07.047 10.1016/j.jaci.2016.08.050 10.1111/all.14033 10.1016/j.jaip.2020.08.048 10.1016/j.alit.2019.10.009 10.1111/all.14702 10.1111/bjd.19312 10.1111/all.14686 10.1016/j.jaci.2014.08.025 10.1016/j.jaci.2019.05.019 10.1159/000509179 10.1046/j.1365-2133.2000.03664.x 10.1016/j.jaip.2017.07.017 10.1111/bjd.17005 10.1016/j.alit.2018.09.006 10.1016/j.jaip.2013.06.003 10.4103/0378-6323.129382 10.1016/j.jaad.2019.07.097 10.1016/j.jaad.2011.06.004 10.1111/j.1365-4632.2006.02655.x 10.1111/ijd.12536 10.1016/j.jaip.2018.12.023 10.1111/j.1365-2222.2004.02019.x 10.1016/j.jaci.2004.06.018 10.1080/09546634.2017.1329505 10.1016/j.jaip.2014.06.004 10.1001/jamadermatol.2018.3715 10.1111/j.1365-2230.1994.tb01168.x 10.1016/j.jdermsci.2017.08.007 10.5935/0305-7518.19910020 10.23822/EurAnnACI.1764-1489.11 10.4103/ijd.IJD_710_16 10.1159/000458152 10.1111/phpp.12008 10.1111/bjd.14778 10.1016/j.jaip.2016.08.010 10.1111/cea.12400 10.1056/NEJMoa1900408 10.1056/NEJMc2016395 10.1016/j.jaip.2018.11.018 10.1111/all.12884 10.1111/all.13878 10.1016/j.jaip.2016.09.029 10.1111/all.14674 10.1016/j.jaip.2015.09.021 10.1111/jdv.13765 10.1016/j.jaip.2018.12.025 10.2332/allergolint.13-OA-0611 10.1016/j.jaci.2017.01.043 10.1016/j.ceca.2010.09.001 10.1016/j.ceca.2011.08.003 10.1016/j.jaip.2020.04.042 10.1034/j.1398-9995.2000.00445.x 10.1016/j.jaci.2017.01.042 10.1111/j.1365-2133.1987.tb04898.x 10.1016/j.jaci.2017.06.032 10.1016/j.jaip.2014.07.008 10.1016/s0140-6736(79)92664-3 10.2332/allergolint.10-OA-0269 10.1111/j.1365-2133.1975.tb03057.x 10.1016/j.jaci.2018.01.031 10.1016/j.jaci.2019.02.005 10.1016/j.jaip.2020.03.004 10.1016/j.jaip.2020.05.016 10.1016/j.jdermsci.2017.02.283 10.1016/j.jaad.2015.11.021 10.1016/j.jaci.2018.08.050 10.1016/j.jaip.2018.02.032 10.1111/bjd.19425 10.1111/bjd.14820 10.1016/j.jaad.2006.04.078 10.1016/j.anai.2017.07.029 10.1016/j.anai.2019.01.006 10.1016/j.waojou.2019.100033 10.4103/2229-5178.156391 10.1001/archderm.142.10.1337 10.1016/j.anai.2013.09.028 10.1067/mai.2002.126676 10.1016/j.jaip.2018.04.026 10.1016/j.anai.2009.12.007 10.1080/000155500750043131 10.2340/00015555-0434 10.3109/09546634.2011.593485 10.1111/cea.13102
Clinical Reviews in Allergy & Immunology; He L, Yi W et. al.
Sep 17th, 2021 - Chronic urticaria (CU) is a common skin condition characterized by the recurrence of wheals, with or without angioedema, which lasts for at least 6 weeks. Owing to its pruritus and incurability, this disease adversely affects the patients' physica...
Guidelines 4 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300800
Allergy Vultaggio A, Agache I et. al.
Jun 6th, 2020 - The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pandemic re-shaped doctor-patient interaction and challenged capacities of healthcare systems. It created many issues around the optimal and safest way to treat complex pat...
https://doi.org/10.1111/all.13397
Allergy Zuberbier T, Aberer W et. al.
Jan 18th, 2018 - This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. I...
https://doi.org/10.1111/all.12370
Allergy Zuberbier T, Aberer W et. al.
Jun 6th, 2014 - This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured con...
https://doi.org/10.1111/j.1524-4725.2010.01495.x
Dermatologic Surgery : Official Publication for American ... Rabe E, Pannier F
Jul 16th, 2010 - Sclerotherapy involves the injection of a sclerosing agent for the elimination of intracutaneous, subcutaneous, and transfascial varicose veins. To update guidelines for sclerotherapy of varicose veins. The guidelines for sclerotherapy of varicose...
Drugs 819 results see all →
News 222 results
https://www.medscape.com/viewarticle/943589
Jan 5th, 2021 - A diagnosis of atopic dermatitis in individuals ages 15 years or older, compared with controls without atopic dermatitis, was nearly twice as likely to be associated with autoimmune disease, in a case control study derived from Swedish national he...
https://www.medscape.com/viewarticle/938263
Sep 30th, 2020 - NEW YORK (Reuters Health) - Pressure urticaria in an infant can be misdiagnosed as physical abuse, according to a case report. "While physicians and healthcare providers should be keen on screening for mistreatment, different presentations of skin...
https://www.medscape.com/viewarticle/937178
Sep 11th, 2020 - NEW YORK (Reuters Health) - Dual histamine-receptor blockade with cetirizine and famotidine appears to reduce pulmonary symptoms and may have other benefits in patients with COVID-19, according to a new study. "We are excited about the global pote...
https://reference.staging.medscape.com/viewarticle/936716_3
Sep 8th, 2020 - Although anaphylaxis can occur without skin symptoms, cutaneous reactions are the most common clinical manifestations of an allergic reaction to a food or food additive. Peanuts remain the most common cause of severe food allergy symptoms and anap...
https://www.medscape.com/viewarticle/935718
Aug 14th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Many COVID-19 treatments, in addition to the infection, may be associated with adverse skin reactions and should be considered in a differential d...
